The partners at the centre of Blis patent dispute named

The partners at the centre of Blis patent dispute named
The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)
Denise McNabb
Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

More Markets

The simple strategy behind Dairyworks
Primary Sector

The simple strategy behind Dairyworks

Is New Zealand still fixated on the 1kg block of cheese?

Trump-era FX 'compounding' margin losses, analysts say
Retail

Trump-era FX 'compounding' margin losses, analysts say

"Liberation day" could make matters worse, says Kiwibank’s Kerr.

NZ sharemarket up 0.3%, Tower dominates trading
Markets Market Close

NZ sharemarket up 0.3%, Tower dominates trading

The S&P/NZX 50 Index closed at 12,312.6, up 42.6 points or 0.35%.

Graham Skellern 01 Apr 2025
Behind the rise of shareholder activism
Markets

Behind the rise of shareholder activism

Activists can be seen as 'baddies', but a new report says there are benefits.